Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

999
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
999
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

46
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
46
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

72
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
72

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redo Transcatheter Aortic Valve Replacement for Degenerated Valve With High-Risk Coronary Anatomy.

JACC. Case reports·2026
Same author

Balloon-Assisted and Snare-Facilitated Retrieval of a Kinked Radial Catheter Entrapped in the Axillary Artery.

JACC. Case reports·2026
Same author

Tricuspid Transcatheter Edge-to-Edge Repair in Orthotopic Heart Transplantation Recipients.

JACC. Case reports·2026
Same author

Embolization Followed by Self-Repositioning of a CardioMEMS™ Wireless Pulmonary Artery Hemodynamic Monitoring Sensor Device.

Methodist DeBakey cardiovascular journal·2026
Same author

Transcatheter Paravalvular Leak Closure Using Valve Frame Access.

JACC. Case reports·2026
Same author

Pericardiocentesis vs. surgical pericardial window for first occurrence of malignancy-related pericardial effusion: a meta-analysis of retrospective studies.

European heart journal open·2026

Related Experiment Video

Updated: Sep 11, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K

Temporary Mechanical Circulatory Support for Acute Myocardial Infarction Cardiogenic Shock.

Saliha Erdem1, Dhruvil Ashishkumar Patel2, Karl Abou Zeid3

  • 1Houston Methodist, Houston, Texas, US.

Methodist Debakey Cardiovascular Journal
|August 18, 2025
PubMed
Summary

Temporary mechanical circulatory support (tMCS) devices offer improved outcomes for patients experiencing cardiogenic shock (CS) after acute myocardial infarction (AMI). This review evaluates tMCS evidence and guidelines to aid clinical decision-making.

Keywords:
MCSacute coronary syndromecardiogenic shockmyocardial infarctionshock

More Related Videos

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

22.1K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K

Related Experiment Videos

Last Updated: Sep 11, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

22.1K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) presents significant challenges with high mortality rates.
  • Temporary mechanical circulatory support (tMCS) is increasingly favored for hemodynamic stabilization and improved survival in AMI-CS.

Purpose of the Study:

  • To review the pathophysiology of AMI-CS.
  • To examine evidence and guidelines for implementing tMCS devices in AMI-CS.
  • To assist clinicians in decision-making regarding tMCS use.

Main Methods:

  • Literature review focusing on clinical trial data and recent guideline recommendations.
  • Examination of the pathophysiology of AMI-CS.
  • Evaluation of various tMCS devices including intra-aortic balloon pump, Impella, TandemHeart, and venoarterial extracorporeal membrane oxygenation.

Main Results:

  • tMCS devices can effectively stabilize hemodynamics and improve cardiac output in patients with AMI-CS.
  • Evidence from clinical trials and guidelines supports the use of tMCS for selected patients.
  • Specific tMCS devices show varying degrees of efficacy and operator preference.

Conclusions:

  • tMCS plays a crucial role in managing cardiogenic shock complicating acute myocardial infarction.
  • Understanding the evidence base and guideline recommendations is essential for optimal tMCS implementation.
  • Further research may refine device selection and patient management strategies in AMI-CS.